Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available. The National Institute for Health and Care Excellence (Nice) announced that it has reversed an initial decision to reject the drug for widespread use for the NHS in England Key points and original sources are listed below.

• Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.S1

• The National Institute for Health and Care Excellence (Nice) announced that it has reversed an initial decision to reject the drug for widespread use for the NHS in EnglandS2